img

Global Human Oral Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Oral Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The global Human Oral Vaccine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Human Oral Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Human Oral Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Human Oral Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Human Oral Vaccine include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Human Oral Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Human Oral Vaccine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Human Oral Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Human Oral Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
By Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
By Application
Public
Private
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Human Oral Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Human Oral Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Oral Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Human Oral Vaccine Definition
1.2 Market by Type
1.2.1 Global Human Oral Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.2.5 Other
1.3 Market Segment by Application
1.3.1 Global Human Oral Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Human Oral Vaccine Sales
2.1 Global Human Oral Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Human Oral Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Human Oral Vaccine Revenue by Region
2.3.1 Global Human Oral Vaccine Revenue by Region (2018-2024)
2.3.2 Global Human Oral Vaccine Revenue by Region (2024-2034)
2.4 Global Human Oral Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Human Oral Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Human Oral Vaccine Sales Quantity by Region
2.6.1 Global Human Oral Vaccine Sales Quantity by Region (2018-2024)
2.6.2 Global Human Oral Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Human Oral Vaccine Sales Quantity by Manufacturers
3.1.1 Global Human Oral Vaccine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Human Oral Vaccine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Human Oral Vaccine Sales in 2022
3.2 Global Human Oral Vaccine Revenue by Manufacturers
3.2.1 Global Human Oral Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Oral Vaccine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Oral Vaccine Revenue in 2022
3.3 Global Human Oral Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Human Oral Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Oral Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Oral Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Human Oral Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Human Oral Vaccine Sales Quantity by Type
4.1.1 Global Human Oral Vaccine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Human Oral Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Human Oral Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Human Oral Vaccine Revenue by Type
4.2.1 Global Human Oral Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Human Oral Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Human Oral Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Human Oral Vaccine Price by Type
4.3.1 Global Human Oral Vaccine Price by Type (2018-2024)
4.3.2 Global Human Oral Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Human Oral Vaccine Sales Quantity by Application
5.1.1 Global Human Oral Vaccine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Human Oral Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Human Oral Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Human Oral Vaccine Revenue by Application
5.2.1 Global Human Oral Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Human Oral Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Human Oral Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Human Oral Vaccine Price by Application
5.3.1 Global Human Oral Vaccine Price by Application (2018-2024)
5.3.2 Global Human Oral Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Human Oral Vaccine Sales by Company
6.1.1 North America Human Oral Vaccine Revenue by Company (2018-2024)
6.1.2 North America Human Oral Vaccine Sales Quantity by Company (2018-2024)
6.2 North America Human Oral Vaccine Market Size by Type
6.2.1 North America Human Oral Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Human Oral Vaccine Revenue by Type (2018-2034)
6.3 North America Human Oral Vaccine Market Size by Application
6.3.1 North America Human Oral Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Human Oral Vaccine Revenue by Application (2018-2034)
6.4 North America Human Oral Vaccine Market Size by Country
6.4.1 North America Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Human Oral Vaccine Revenue by Country (2018-2034)
6.4.3 North America Human Oral Vaccine Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Human Oral Vaccine Sales by Company
7.1.1 Europe Human Oral Vaccine Sales Quantity by Company (2018-2024)
7.1.2 Europe Human Oral Vaccine Revenue by Company (2018-2024)
7.2 Europe Human Oral Vaccine Market Size by Type
7.2.1 Europe Human Oral Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Human Oral Vaccine Revenue by Type (2018-2034)
7.3 Europe Human Oral Vaccine Market Size by Application
7.3.1 Europe Human Oral Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Human Oral Vaccine Revenue by Application (2018-2034)
7.4 Europe Human Oral Vaccine Market Size by Country
7.4.1 Europe Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Human Oral Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Human Oral Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Human Oral Vaccine Sales by Company
8.1.1 China Human Oral Vaccine Sales Quantity by Company (2018-2024)
8.1.2 China Human Oral Vaccine Revenue by Company (2018-2024)
8.2 China Human Oral Vaccine Market Size by Type
8.2.1 China Human Oral Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Human Oral Vaccine Revenue by Type (2018-2034)
8.3 China Human Oral Vaccine Market Size by Application
8.3.1 China Human Oral Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Human Oral Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Human Oral Vaccine Sales by Company
9.1.1 APAC Human Oral Vaccine Sales Quantity by Company (2018-2024)
9.1.2 APAC Human Oral Vaccine Revenue by Company (2018-2024)
9.2 APAC Human Oral Vaccine Market Size by Type
9.2.1 APAC Human Oral Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Human Oral Vaccine Revenue by Type (2018-2034)
9.3 APAC Human Oral Vaccine Market Size by Application
9.3.1 APAC Human Oral Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Human Oral Vaccine Revenue by Application (2018-2034)
9.4 APAC Human Oral Vaccine Market Size by Region
9.4.1 APAC Human Oral Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Human Oral Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Human Oral Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Oral Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Human Oral Vaccine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Human Oral Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Human Oral Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Human Oral Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Human Oral Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Human Oral Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Human Oral Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck Human Oral Vaccine Products and Services
11.1.5 Merck Human Oral Vaccine SWOT Analysis
11.1.6 Merck Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 GSK Human Oral Vaccine Products and Services
11.2.5 GSK Human Oral Vaccine SWOT Analysis
11.2.6 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Sanofi Human Oral Vaccine Products and Services
11.3.5 Sanofi Human Oral Vaccine SWOT Analysis
11.3.6 Sanofi Recent Developments
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Company Information
11.4.2 Lanzhou Institute Overview
11.4.3 Lanzhou Institute Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Lanzhou Institute Human Oral Vaccine Products and Services
11.4.5 Lanzhou Institute Human Oral Vaccine SWOT Analysis
11.4.6 Lanzhou Institute Recent Developments
11.5 Serum Institute
11.5.1 Serum Institute Company Information
11.5.2 Serum Institute Overview
11.5.3 Serum Institute Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Serum Institute Human Oral Vaccine Products and Services
11.5.5 Serum Institute Human Oral Vaccine SWOT Analysis
11.5.6 Serum Institute Recent Developments
11.6 Valneva
11.6.1 Valneva Company Information
11.6.2 Valneva Overview
11.6.3 Valneva Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Valneva Human Oral Vaccine Products and Services
11.6.5 Valneva Human Oral Vaccine SWOT Analysis
11.6.6 Valneva Recent Developments
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Company Information
11.7.2 Shanghai United Cell Overview
11.7.3 Shanghai United Cell Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Shanghai United Cell Human Oral Vaccine Products and Services
11.7.5 Shanghai United Cell Human Oral Vaccine SWOT Analysis
11.7.6 Shanghai United Cell Recent Developments
11.8 Bibcol
11.8.1 Bibcol Company Information
11.8.2 Bibcol Overview
11.8.3 Bibcol Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Bibcol Human Oral Vaccine Products and Services
11.8.5 Bibcol Human Oral Vaccine SWOT Analysis
11.8.6 Bibcol Recent Developments
11.9 PaxVax
11.9.1 PaxVax Company Information
11.9.2 PaxVax Overview
11.9.3 PaxVax Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 PaxVax Human Oral Vaccine Products and Services
11.9.5 PaxVax Human Oral Vaccine SWOT Analysis
11.9.6 PaxVax Recent Developments
11.10 Vabiotech
11.10.1 Vabiotech Company Information
11.10.2 Vabiotech Overview
11.10.3 Vabiotech Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Vabiotech Human Oral Vaccine Products and Services
11.10.5 Vabiotech Human Oral Vaccine SWOT Analysis
11.10.6 Vabiotech Recent Developments
11.11 Tiantan Biological
11.11.1 Tiantan Biological Company Information
11.11.2 Tiantan Biological Overview
11.11.3 Tiantan Biological Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Tiantan Biological Human Oral Vaccine Products and Services
11.11.5 Tiantan Biological Recent Developments
11.12 EuBiologics
11.12.1 EuBiologics Company Information
11.12.2 EuBiologics Overview
11.12.3 EuBiologics Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 EuBiologics Human Oral Vaccine Products and Services
11.12.5 EuBiologics Recent Developments
11.13 Panacea Biotec Ltd
11.13.1 Panacea Biotec Ltd Company Information
11.13.2 Panacea Biotec Ltd Overview
11.13.3 Panacea Biotec Ltd Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Panacea Biotec Ltd Human Oral Vaccine Products and Services
11.13.5 Panacea Biotec Ltd Recent Developments
11.14 Bio-Med
11.14.1 Bio-Med Company Information
11.14.2 Bio-Med Overview
11.14.3 Bio-Med Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Bio-Med Human Oral Vaccine Products and Services
11.14.5 Bio-Med Recent Developments
11.15 Halfkin Bio-Pharmaceuticals
11.15.1 Halfkin Bio-Pharmaceuticals Company Information
11.15.2 Halfkin Bio-Pharmaceuticals Overview
11.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Products and Services
11.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Oral Vaccine Value Chain Analysis
12.2 Human Oral Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Oral Vaccine Production Mode & Process
12.4 Human Oral Vaccine Sales and Marketing
12.4.1 Human Oral Vaccine Sales Channels
12.4.2 Human Oral Vaccine Distributors
12.5 Human Oral Vaccine Customers
13 Market Dynamics
13.1 Human Oral Vaccine Industry Trends
13.2 Human Oral Vaccine Market Drivers
13.3 Human Oral Vaccine Market Challenges
13.4 Human Oral Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Oral Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Rotavirus Vaccine
Table 3. Major Manufacturers of Cholera Vaccine
Table 4. Major Manufacturers of Oral Polio Vaccine
Table 5. Major Manufacturers of Other
Table 6. Global Human Oral Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Human Oral Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Human Oral Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Human Oral Vaccine Revenue Market Share by Region (2018-2024)
Table 10. Global Human Oral Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Human Oral Vaccine Revenue Market Share by Region (2024-2034)
Table 12. Global Human Oral Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 13. Global Human Oral Vaccine Sales by Region (2018-2024) & (K Units)
Table 14. Global Human Oral Vaccine Sales Market Share by Region (2018-2024)
Table 15. Global Human Oral Vaccine Sales by Region (2024-2034) & (K Units)
Table 16. Global Human Oral Vaccine Sales Market Share by Region (2024-2034)
Table 17. Global Human Oral Vaccine Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 18. Global Human Oral Vaccine Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Human Oral Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Human Oral Vaccine Revenue Share by Manufacturers (2018-2024)
Table 21. Global Human Oral Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Key Players of Human Oral Vaccine, Industry Ranking, 2021 VS 2022
Table 23. Global Human Oral Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Human Oral Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Oral Vaccine as of 2022)
Table 25. Global Key Manufacturers of Human Oral Vaccine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Human Oral Vaccine, Product Offered and Application
Table 27. Global Key Manufacturers of Human Oral Vaccine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Human Oral Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 30. Global Human Oral Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global Human Oral Vaccine Sales Quantity Share by Type (2018-2024)
Table 32. Global Human Oral Vaccine Sales Quantity Share by Type (2024-2034)
Table 33. Global Human Oral Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Human Oral Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Human Oral Vaccine Revenue Share by Type (2018-2024)
Table 36. Global Human Oral Vaccine Revenue Share by Type (2024-2034)
Table 37. Human Oral Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Human Oral Vaccine Price Forecast by Type (2024-2034) & (US$/Unit)
Table 39. Global Human Oral Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 40. Global Human Oral Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global Human Oral Vaccine Sales Quantity Share by Application (2018-2024)
Table 42. Global Human Oral Vaccine Sales Quantity Share by Application (2024-2034)
Table 43. Global Human Oral Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Human Oral Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Human Oral Vaccine Revenue Share by Application (2018-2024)
Table 46. Global Human Oral Vaccine Revenue Share by Application (2024-2034)
Table 47. Human Oral Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Human Oral Vaccine Price Forecast by Application (2024-2034) & (US$/Unit)
Table 49. North America Human Oral Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Human Oral Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 51. North America Human Oral Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 52. North America Human Oral Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America Human Oral Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Human Oral Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Human Oral Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 56. North America Human Oral Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America Human Oral Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Human Oral Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Human Oral Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Human Oral Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Human Oral Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 63. North America Human Oral Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe Human Oral Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 65. Europe Human Oral Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Human Oral Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 67. Europe Human Oral Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe Human Oral Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Human Oral Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Human Oral Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 71. Europe Human Oral Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe Human Oral Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Human Oral Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Human Oral Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Human Oral Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Human Oral Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 78. Europe Human Oral Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China Human Oral Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 80. China Human Oral Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Human Oral Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 82. China Human Oral Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China Human Oral Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Human Oral Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Human Oral Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 86. China Human Oral Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China Human Oral Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Human Oral Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Human Oral Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 90. APAC Human Oral Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Human Oral Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 92. APAC Human Oral Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC Human Oral Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Human Oral Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Human Oral Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 96. APAC Human Oral Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC Human Oral Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Human Oral Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Human Oral Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Human Oral Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Human Oral Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Human Oral Vaccine Sales Quantity by Region (2018-2024) & (K Units)
Table 103. APAC Human Oral Vaccine Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Human Oral Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Human Oral Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Human Oral Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Human Oral Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Human Oral Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Human Oral Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Human Oral Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Human Oral Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 118. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Merck Company Information
Table 120. Merck Description and Overview
Table 121. Merck Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 122. Merck Human Oral Vaccine Product and Services
Table 123. Merck Human Oral Vaccine SWOT Analysis
Table 124. Merck Recent Developments
Table 125. GSK Company Information
Table 126. GSK Description and Overview
Table 127. GSK Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 128. GSK Human Oral Vaccine Product and Services
Table 129. GSK Human Oral Vaccine SWOT Analysis
Table 130. GSK Recent Developments
Table 131. Sanofi Company Information
Table 132. Sanofi Description and Overview
Table 133. Sanofi Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 134. Sanofi Human Oral Vaccine Product and Services
Table 135. Sanofi Human Oral Vaccine SWOT Analysis
Table 136. Sanofi Recent Developments
Table 137. Lanzhou Institute Company Information
Table 138. Lanzhou Institute Description and Overview
Table 139. Lanzhou Institute Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 140. Lanzhou Institute Human Oral Vaccine Product and Services
Table 141. Lanzhou Institute Human Oral Vaccine SWOT Analysis
Table 142. Lanzhou Institute Recent Developments
Table 143. Serum Institute Company Information
Table 144. Serum Institute Description and Overview
Table 145. Serum Institute Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 146. Serum Institute Human Oral Vaccine Product and Services
Table 147. Serum Institute Human Oral Vaccine SWOT Analysis
Table 148. Serum Institute Recent Developments
Table 149. Valneva Company Information
Table 150. Valneva Description and Overview
Table 151. Valneva Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 152. Valneva Human Oral Vaccine Product and Services
Table 153. Valneva Human Oral Vaccine SWOT Analysis
Table 154. Valneva Recent Developments
Table 155. Shanghai United Cell Company Information
Table 156. Shanghai United Cell Description and Overview
Table 157. Shanghai United Cell Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 158. Shanghai United Cell Human Oral Vaccine Product and Services
Table 159. Shanghai United Cell Human Oral Vaccine SWOT Analysis
Table 160. Shanghai United Cell Recent Developments
Table 161. Bibcol Company Information
Table 162. Bibcol Description and Overview
Table 163. Bibcol Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 164. Bibcol Human Oral Vaccine Product and Services
Table 165. Bibcol Human Oral Vaccine SWOT Analysis
Table 166. Bibcol Recent Developments
Table 167. PaxVax Company Information
Table 168. PaxVax Description and Overview
Table 169. PaxVax Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 170. PaxVax Human Oral Vaccine Product and Services
Table 171. PaxVax Human Oral Vaccine SWOT Analysis
Table 172. PaxVax Recent Developments
Table 173. Vabiotech Company Information
Table 174. Vabiotech Description and Overview
Table 175. Vabiotech Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 176. Vabiotech Human Oral Vaccine Product and Services
Table 177. Vabiotech Human Oral Vaccine SWOT Analysis
Table 178. Vabiotech Recent Developments
Table 179. Tiantan Biological Company Information
Table 180. Tiantan Biological Description and Overview
Table 181. Tiantan Biological Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 182. Tiantan Biological Human Oral Vaccine Product and Services
Table 183. Tiantan Biological Recent Developments
Table 184. EuBiologics Company Information
Table 185. EuBiologics Description and Overview
Table 186. EuBiologics Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 187. EuBiologics Human Oral Vaccine Product and Services
Table 188. EuBiologics Recent Developments
Table 189. Panacea Biotec Ltd Company Information
Table 190. Panacea Biotec Ltd Description and Overview
Table 191. Panacea Biotec Ltd Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 192. Panacea Biotec Ltd Human Oral Vaccine Product and Services
Table 193. Panacea Biotec Ltd Recent Developments
Table 194. Bio-Med Company Information
Table 195. Bio-Med Description and Overview
Table 196. Bio-Med Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 197. Bio-Med Human Oral Vaccine Product and Services
Table 198. Bio-Med Recent Developments
Table 199. Halfkin Bio-Pharmaceuticals Company Information
Table 200. Halfkin Bio-Pharmaceuticals Description and Overview
Table 201. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 202. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product and Services
Table 203. Halfkin Bio-Pharmaceuticals Recent Developments
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Human Oral Vaccine Distributors List
Table 207. Human Oral Vaccine Customers List
Table 208. Human Oral Vaccine Market Trends
Table 209. Human Oral Vaccine Market Drivers
Table 210. Human Oral Vaccine Market Challenges
Table 211. Human Oral Vaccine Market Restraints
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Oral Vaccine Product Picture
Figure 2. Global Human Oral Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Oral Vaccine Market Share by Type in 2022 & 2034
Figure 4. Rotavirus Vaccine Product Picture
Figure 5. Cholera Vaccine Product Picture
Figure 6. Oral Polio Vaccine Product Picture
Figure 7. Other Product Picture
Figure 8. Global Human Oral Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Human Oral Vaccine Market Share by Application in 2022 & 2034
Figure 10. Public
Figure 11. Private
Figure 12. Human Oral Vaccine Report Years Considered
Figure 13. Global Human Oral Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Human Oral Vaccine Revenue 2018-2034 (US$ Million)
Figure 15. Global Human Oral Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Human Oral Vaccine Sales Quantity 2018-2034 (K Units)
Figure 17. Global Human Oral Vaccine Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Human Oral Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Human Oral Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Human Oral Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Human Oral Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Human Oral Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Human Oral Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Human Oral Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Human Oral Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Human Oral Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Human Oral Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Human Oral Vaccine Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Human Oral Vaccine Revenue in 2022
Figure 31. Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Human Oral Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Human Oral Vaccine Revenue Market Share by Type (2018-2034)
Figure 34. Global Human Oral Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Human Oral Vaccine Revenue Market Share by Application (2018-2034)
Figure 36. North America Human Oral Vaccine Revenue Market Share by Company in 2022
Figure 37. North America Human Oral Vaccine Sales Quantity Market Share by Company in 2022
Figure 38. North America Human Oral Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Human Oral Vaccine Revenue Market Share by Type (2018-2034)
Figure 40. North America Human Oral Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Human Oral Vaccine Revenue Market Share by Application (2018-2034)
Figure 42. North America Human Oral Vaccine Revenue Share by Country (2018-2034)
Figure 43. North America Human Oral Vaccine Sales Quantity Share by Country (2018-2034)
Figure 44. United States Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Human Oral Vaccine Sales Quantity Market Share by Company in 2022
Figure 47. Europe Human Oral Vaccine Revenue Market Share by Company in 2022
Figure 48. Europe Human Oral Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Human Oral Vaccine Revenue Market Share by Type (2018-2034)
Figure 50. Europe Human Oral Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Human Oral Vaccine Revenue Market Share by Application (2018-2034)
Figure 52. Europe Human Oral Vaccine Revenue Share by Country (2018-2034)
Figure 53. Europe Human Oral Vaccine Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 55. France Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 59. China Human Oral Vaccine Sales Quantity Market Share by Company in 2022
Figure 60. China Human Oral Vaccine Revenue Market Share by Company in 2022
Figure 61. China Human Oral Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Human Oral Vaccine Revenue Market Share by Type (2018-2034)
Figure 63. China Human Oral Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Human Oral Vaccine Revenue Market Share by Application (2018-2034)
Figure 65. APAC Human Oral Vaccine Sales Quantity Market Share by Company in 2022
Figure 66. APAC Human Oral Vaccine Revenue Market Share by Company in 2022
Figure 67. APAC Human Oral Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Human Oral Vaccine Revenue Market Share by Type (2018-2034)
Figure 69. APAC Human Oral Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Human Oral Vaccine Revenue Market Share by Application (2018-2034)
Figure 71. APAC Human Oral Vaccine Revenue Share by Region (2018-2034)
Figure 72. APAC Human Oral Vaccine Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 77. India Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Human Oral Vaccine Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Human Oral Vaccine Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Human Oral Vaccine Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Human Oral Vaccine Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Human Oral Vaccine Revenue Share by Country (2018-2034)
Figure 86. Brazil Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Human Oral Vaccine Revenue (2018-2034) & (US$ Million)
Figure 91. Human Oral Vaccine Value Chain
Figure 92. Human Oral Vaccine Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries